Rapid genome sequence analysis permitted us to genetically define this strain, rule out the likelihood of bioterrorism, and contribute effectively to the institutional response to this event. Our experience strongly reinforced the critical value of deploying a well-integrated, anatomic, clinical, and genomic strategy to respond rapidly to a potential emerging, infectious threat to public health.
A 39‐year‐old male presented with a rapidly progressive hemorrhagic anthrax‐like pneumonia. Within 3 days, the overwhelming systemic infection proved fatal. Microbial culture of antemortem and postmortem specimens grew pure cultures of Gram‐positive rods that were provisionally identified as Bacillus species. An autopsy was performed, and we characterized the genome of a strain isolated from the patient's blood within days using next‐generation sequencing technology. In addition, the genomes of sixteen strains recovered from different anatomic sites and time points were fully sequenced to assess intra‐host genetic variation. Whole genome analysis demonstrated that the fatal infection was caused by a previously unknown strain of B. cereus that was closely related to, but genetically distinct from, B anthracis. The exceptional virulence of this B. cereus strain was due in part to carriage of a pXO1‐like plasmid that encodes the tripartite anthrax toxin. The sequence data revealed the molecular determinants leading to the exceptional virulence of this organism, helped guide the institutional infection control response, and provided new insight to host‐pathogen interactions. This case exemplifies the value of autopsy and whole genome sequencing technologies to laboratory medicine.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.